📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-23 12:21
232 analysed today
FollowTelegram
232
Today
149,633
All-time analysed
42,906
Positive
6,661
Negative
91,389
Neutral
8,609
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
25 announcements match the current filters (relevance ≥ 5).
PGHH Denies Market Rumours of Delisting and Winding Up Operations
Procter & Gamble Hygiene and Health Care Limited (PGHH) issued a clarification under Regulation 30(11) following material price movements. The company categorically denied market rumours regarding a potential delisting or winding up of its operations, labeling them as baseless. This comes amid a steep 46.0% drop in share price over the past 12 months, despite stable promoter shareholding at 70.64%. The company affirmed that any price-sensitive information will be formally communicated via regulatory disclosures.
Confidence: HIGH
What changedPGHH has formally clarified and denied persistent market rumours about delisting or operational winding down.
Why it mattersDispels extreme downside speculation that may have contributed to severe share price volatility and the stock's 46% decline over the past year.
Promoter holding (Mar 2026): 70.64%12-month price return: -46.0%Net profit (Dec 2025): ₹301.46 cr
📅 Short termMay help curtail speculative selling driven by delisting/closure rumours over the next few sessions.
📈 Long termLimited; fundamental performance in feminine care and healthcare, alongside margin resilience, remains the primary driver.
⚠ Risk flags
- Elevated market volatility driven by unsubstantiated market rumours
Key Highlights
Categorically denied rumours regarding potential delisting or winding up of operations on September 23, 2026
Filing made under Regulation 30(11) in response to material price movements
Promoter shareholding remains stable at 70.64% as of March 2026
Clarification follows a 12-month share price decline of 46.0%
👀 What to Watch
Track trading volumes and price stability following the clarification, along with upcoming quarterly earnings disclosures to evaluate core business health.
₹901 Cr Sales: PGHH Reports 5% Revenue Decline and PAT Compression in June 2026 Quarter
Procter & Gamble Hygiene and Health Care (PGHH) reported a 5% year-on-year decline in sales to ₹901 crores for the quarter ended June 30, 2026. Profit After Tax (PAT) came in at ₹126 crores, a sharp decline from the ₹192.06 crores reported in the same quarter last year. The company cited commodity cost fluctuations driven by geopolitical uncertainties and a deliberate increase in advertising and promotional (A&P) spending as primary reasons for the margin pressure. Despite the slowdown, the company continues to focus on its 'Integrated Growth Strategy' and product superiority in the feminine hygiene and healthcare segments.
Confidence: HIGH
What changedPGHH experienced a contraction in both top-line revenue and bottom-line profitability for the quarter ended June 30, 2026, compared to the previous year.
Why it mattersThe results reflect a challenging operating environment where cost inflation and the need for higher marketing support are squeezing margins for even high-ROCE multinational brands.
Sales (Q1 FY27): ₹901 crSales Growth (YoY): -5%Profit After Tax (Q1 FY27): ₹126 crPAT (Q1 FY26): ₹192.06 crROCE: 157.0%
📅 Short termThe stock may face downward pressure in the short term as the market reacts to the decline in both revenue and PAT compared to the previous year.
📈 Long termWhile the current quarter is weak, the company's structural moat remains strong due to its market-leading brands (Whisper, Vicks) and high capital efficiency, though growth has moderated to the mid-single digits.
⚠ Risk flags
- Commodity cost volatility
- Increased competitive intensity requiring higher A&P spend
- Soft urban demand impacting premium segments
Key Highlights
Quarterly sales declined by 5% year-on-year to ₹901 crores.
Profit After Tax (PAT) stood at ₹126 crores, down significantly from ₹192.06 crores in the year-ago period.
Increased advertising and promotional expenses were incurred to maintain long-term competitiveness.
Commodity cost fluctuations due to geopolitical uncertainties impacted the bottom line.
The company maintains a high ROCE of 157.0% and a strong promoter holding of 70.64%.
👀 What to Watch
Investors should monitor whether the increased advertising spend translates into volume growth in subsequent quarters and watch for any stabilization in raw material costs. The focus remains on the recovery of urban demand and the performance of premium launches like Whisper Period Pants.
PGHH Q4 Net Profit Drops 34.3% YoY to ₹126.27 Cr; Revenue Declines 4.9%
Procter & Gamble Hygiene and Health Care (PGHH) reported a weak set of results for the quarter ended June 30, 2026. Revenue from operations declined 4.9% YoY to ₹891.46 Cr, while Net Profit saw a sharp contraction of 34.3% YoY to ₹126.27 Cr. The bottom line was significantly impacted by a 21.2% increase in advertising and sales promotion expenses, which rose to ₹83.32 Cr despite falling sales. Profit Before Tax (PBT) also fell sharply by 35.9% YoY to ₹169.63 Cr, indicating substantial margin pressure.
Confidence: HIGH
What changedThe company experienced a simultaneous decline in both top-line and bottom-line performance, with a notable spike in marketing costs failing to drive revenue growth.
Why it mattersThe sharp drop in profitability for a high-ROCE (157%) company suggests either intense competitive pressure in the feminine hygiene/healthcare segments or a significant slowdown in consumer off-take for premium products.
Revenue (Jun 2026): ₹891.46 CrNet Profit (Jun 2026): ₹126.27 CrYoY Revenue Growth: -4.9%YoY Net Profit Growth: -34.3%Ad Spend as % of Revenue: 9.35%
📅 Short termThe stock is likely to face downward pressure in the short term due to the significant earnings miss and margin contraction.
📈 Long termWhile the company maintains a strong brand moat with Whisper and Vicks, the structural growth rate and ability to pass on cost inflation/marketing costs will be key to restoring its premium valuation.
⚠ Risk flags
- Significant margin compression
- Negative revenue growth
- Rising advertising costs relative to sales
Key Highlights
Revenue from operations decreased by 4.9% YoY to ₹891.46 Cr from ₹937.03 Cr.
Net Profit for the quarter fell 34.3% YoY to ₹126.27 Cr compared to ₹192.06 Cr in the year-ago period.
Advertising and sales promotion expenses surged 21.2% YoY to ₹83.32 Cr.
Profit Before Tax (PBT) declined to ₹169.63 Cr from ₹264.70 Cr in June 2025.
Basic Earnings Per Share (EPS) dropped to ₹38.90 from ₹59.17 YoY.
👀 What to Watch
Investors should monitor management commentary regarding the effectiveness of increased advertising spends and the trajectory of rural demand recovery, as the current results show significant margin erosion.
PGHH Appoints Gopalakrishnan Kalianna as Sales Head Effective August 1, 2026
Procter & Gamble Hygiene and Health Care Limited (PGHH) has appointed Mr. Gopalakrishnan Kalianna as Sales Head, effective August 1, 2026. He succeeds Ms. Rohini Venkateswaran, who is being elevated to a global role as Senior Vice President-Korea. Mr. Kalianna is a P&G veteran with over 20 years of experience, previously leading India's Go-To-Market strategy and Fabric Care sales. This transition occurs as the company maintains a strong financial profile with a Dec 2025 quarterly revenue of ₹1,261.9 cr and a high ROCE of 157%.
Confidence: HIGH
What changedA leadership transition in the sales function, moving from Ms. Rohini Venkateswaran to Mr. Gopalakrishnan Kalianna.
Why it mattersSales leadership is vital for PGHH to maintain its market-leading positions in feminine hygiene (Whisper) and healthcare (Vicks), especially as it targets 'personalized availability' through quick-commerce.
Effective Date: August 1, 2026Experience of New Sales Head: 2+ decadesDec 2025 Quarterly Revenue: ₹1,261.9 crROCE: 157.0%Promoter Holding: 70.64%
📅 Short termThe announcement is unlikely to impact the stock price in the short term as it represents a planned internal succession within the P&G group.
📈 Long termLimited structural impact; P&G's robust internal talent pipeline typically ensures continuity in business strategy and operational excellence.
Key Highlights
Appointment of Mr. Gopalakrishnan Kalianna as Sales Head effective August 1, 2026
Succession of Ms. Rohini Venkateswaran following her elevation to Senior Vice President-Korea
New appointee brings 2+ decades of experience across brands, channels, and markets
Company reported a net profit of ₹301.46 cr for the quarter ended December 2025
Promoter holding remains stable at 70.64% as of March 2026
👀 What to Watch
Investors should monitor the execution of the company's 'Integrated Growth Strategy' under new sales leadership, particularly in high-growth segments like e-commerce and rural recovery.
PGHH Declares ₹60 Final Dividend for FY 2025-26; Issues TDS Guidelines for Shareholders
Procter & Gamble Hygiene and Health Care Limited (PGHH) has declared a final dividend of ₹60 per equity share for the financial year 2025-26. The company has issued a detailed communication regarding Tax Deducted at Source (TDS) on this dividend income, noting a standard 10% rate for resident shareholders with a valid PAN. Shareholders must submit relevant tax exemption forms or DTAA documents to the Registrar (MUFG Intime India) by August 14, 2026, to ensure appropriate tax treatment. The dividend is subject to approval at the upcoming Annual General Meeting.
Key Highlights
Final dividend of ₹60 per equity share of face value ₹10 declared for FY 2025-26.
Standard TDS rate of 10% for resident shareholders with valid PAN; 20% for invalid or missing PAN.
No TDS for resident individual shareholders if the total dividend amount does not exceed ₹10,000 in the fiscal year.
Non-resident shareholders can avail lower DTAA rates by submitting Tax Residency Certificates and Form 41.
Deadline for submitting tax-related declarations and documents to the RTA is August 14, 2026.
👀 What to Watch
Shareholders should verify that their PAN is linked with Aadhaar and submit Form 121 or relevant DTAA documents to the RTA before August 14 to avoid higher tax withholding.
PGHH FY26 Results: PAT Grows 19% to ₹850 Cr Despite Flat Sales of ₹4,300 Cr
Procter & Gamble Hygiene and Health Care Limited (PGHH) reported flat sales of ₹4,300 crores for the fiscal year ended March 31, 2026. Despite the stagnant top-line growth, the company achieved a 19% increase in Profit After Tax (PAT) to ₹850 crores, driven by aggressive productivity and cost-saving programs. Management is doubling down on its 'integrated growth strategy' focusing on product superiority and premiumization in the Feminine Care and Personal Healthcare segments to navigate a high-inflation and fragmented media environment.
Key Highlights
Reported annual sales of ₹4,300 crores, remaining flat year-on-year due to a challenging operating environment.
Achieved a 19% growth in Profit After Tax (PAT) to ₹850 crores through targeted savings programs.
Upgraded Vicks ZzzQuil Natura with a higher 5mg melatonin dosage and 50mg natural ashwagandha.
Expanded the Feminine Care portfolio with Whisper Period Panties and an upgraded Whisper Nights range.
Management identified quick commerce and agentic AI as transformative shifts in the current retail landscape.
👀 What to Watch
Investors should focus on the company's ability to maintain high margins through productivity gains despite flat revenue growth. Monitor the adoption of premium products like Period Panties and ZzzQuil as indicators of successful brand premiumization in a value-conscious market.
PGHH FY 2025-26: PAT Grows 19% Despite Flat Sales; INR 86 Cr Productivity Savings Achieved
Procter & Gamble Hygiene and Health Care Limited (PGHH) reported a 19% growth in Profit After Tax (PAT) for FY 2025-26 compared to the previous 12-month period, despite flat sales performance. The company successfully realized INR 86 crores in productivity savings across manufacturing, materials, and advertising spend to fuel bottom-line growth. Long-term trends remain healthy with a 10-year PAT CAGR of 8% and a 3x increase in Return on Equity (ROE). Management continues to focus on product superiority in the Feminine Care and Health Care segments while navigating soft consumption trends in both rural and urban markets.
Key Highlights
PAT increased by 19% in FY 2025-26 compared to the indexed 12-month period of the previous year.
Realized INR 86 crores in productivity savings across materials, manufacturing, and overheads.
Maintained a 10-year Net Sales CAGR of 6% and a PAT CAGR of 8%.
Return on Equity (ROE) has increased 3X over the last decade.
Consistent dividend payout record maintained for over three decades.
👀 What to Watch
Investors should view the strong margin expansion and productivity gains as a sign of operational efficiency in a sluggish demand environment. The company remains a solid defensive pick with high ROE and consistent dividends, though monitoring for a recovery in top-line growth is advised.
PGHH Appoints Mohit Pradhan as VP and Category Leader for Feminine Hygiene Business
Procter & Gamble Hygiene and Health Care Limited (PGHH) has announced the appointment of Mr. Mohit Pradhan as Vice President and Category Leader for its Feminine Hygiene Business, effective August 1, 2026. Mr. Pradhan, an IIM Ahmedabad alumnus with 20 years of experience at P&G, succeeds Mr. Girish Kalyanaraman, who will transition to a new role within the P&G group after June 30, 2026. This leadership change is significant as the Feminine Hygiene segment is a core business driver for the company. Mr. Pradhan previously served as VP and General Manager for P&G Indonesia, bringing extensive international experience in general management and commercial strategy.
Key Highlights
Mr. Mohit Pradhan appointed as VP and Category Leader for Feminine Hygiene Business effective August 1, 2026.
Outgoing leader Mr. Girish Kalyanaraman to exit the senior management team on June 30, 2026, for a new P&G assignment.
Mr. Pradhan brings 20 years of experience at P&G, including a recent stint as VP and GM for P&G Indonesia.
The appointee holds an MBA from IIM Ahmedabad and an engineering degree from the Marine Engineering & Research Institute Kolkata.
👀 What to Watch
Investors should view this as a routine leadership transition within the P&G ecosystem. No immediate action is required, though monitoring the performance of the Feminine Hygiene segment under the new leadership is advised.
PGHH FY26 PAT Up 19% to ₹857 Cr; Total Dividend Declared at ₹255 Per Share
Procter & Gamble Hygiene and Health Care Limited (PGHH) reported a 19% increase in Profit After Tax (PAT) to ₹857 crore for FY26, despite flat annual sales of ₹4,290 crore. The growth in profitability was primarily driven by a better product mix and operational efficiencies. However, the fourth quarter showed signs of a slowdown, with sales declining 5% to ₹941 crore and PAT falling 2% to ₹153 crore. A significant highlight for shareholders is the total dividend payout of ₹255 per share for the fiscal year, including a newly recommended final dividend of ₹60.
Key Highlights
Annual Profit After Tax (PAT) rose 19% to ₹857 crore for the fiscal year ended March 31, 2026.
Full-year sales remained stagnant at ₹4,290 crore compared to the previous 12-month period.
Q4 sales and PAT declined by 5% and 2% respectively, indicating a challenging quarter.
Total dividend for the year reached ₹255 per share, including a final dividend of ₹60.
Profitability gains were attributed to product mix and productivity rather than top-line growth.
👀 What to Watch
Investors should focus on the high dividend yield and margin resilience but remain cautious about the stagnant revenue growth and Q4 decline. The stock remains a solid defensive pick for income-seeking investors, though volume growth needs to be monitored.
PGHH Appoints Srividya Srinivasan as CFO; Gaurav Bhartia to Step Down Effective June 30, 2026
Procter & Gamble Hygiene and Health Care Limited (PGHH) has announced a significant leadership transition effective July 1, 2026. Mr. Gaurav Bhartia will resign as CFO to take up a new assignment within the global P&G group, and will be replaced by Ms. Srividya Srinivasan, who brings 20 years of finance experience. Additionally, Mr. Ghanashyam Hegde will transition from his role as Company Secretary to a Non-Executive Director, ensuring continuity on the board. These changes appear to be part of P&G's standard internal talent rotation strategy.
Key Highlights
Ms. Srividya Srinivasan appointed as Executive Director and CFO for a 5-year term starting July 1, 2026.
Current CFO Gaurav Bhartia to step down on June 30, 2026, to pursue a different assignment within P&G.
Mr. Ghanashyam Hegde re-designated as Non-Executive Director effective July 1, 2026, after resigning as Company Secretary.
Incoming CFO Srividya Srinivasan has 20 years of experience across P&G markets including USA, Latin America, and Philippines.
👀 What to Watch
Investors should view this as a routine management rotation typical of multinational corporations; no immediate action is required as the transition period is well-defined.
PGHH Appoints Srividya Srinivasan as CFO; Ghanashyam Hegde Re-designated as Non-Executive Director
Procter & Gamble Hygiene and Health Care Limited (PGHH) has announced a significant leadership transition effective July 1, 2026. Ms. Srividya Srinivasan, a P&G veteran with 20 years of global experience, has been appointed as the new Chief Financial Officer and Executive Director for a five-year term. She succeeds Mr. Gaurav Bhartia, who is moving to a new assignment within the P&G group. Additionally, Mr. Ghanashyam Hegde will transition from his role as Company Secretary to a Non-Executive Director position on the board.
Key Highlights
Ms. Srividya Srinivasan appointed as CFO and Executive Director for a 5-year term starting July 1, 2026.
Outgoing CFO Gaurav Bhartia to resign effective June 30, 2026, to take up a new assignment within P&G.
Mr. Ghanashyam Hegde re-designated as Non-Executive Director effective July 1, 2026, while moving to a regional VP role.
New CFO Srividya Srinivasan brings 20 years of finance experience across markets including USA, Latin America, and Philippines.
👀 What to Watch
Investors should view this as a routine leadership rotation typical of multinational corporations; no immediate action is required as the transition appears well-planned for July 2026.
PGHH Appoints Srividya Srinivasan as CFO; Gaurav Bhartia to Step Down
Procter & Gamble Hygiene and Health Care Limited (PGHH) has announced a leadership transition effective July 1, 2026. Ms. Srividya Srinivasan, a P&G veteran with 20 years of experience, will take over as Executive Director and CFO for a five-year term. She succeeds Mr. Gaurav Bhartia, who is moving to a new assignment within the P&G group. Additionally, Mr. Ghanashyam Hegde will transition from Company Secretary to a Non-Executive Director role.
Key Highlights
Ms. Srividya Srinivasan appointed as CFO and Executive Director for a 5-year term starting July 1, 2026.
Outgoing CFO Gaurav Bhartia to cease his role on June 30, 2026, moving to a different assignment within P&G.
Ms. Srinivasan brings 20 years of global finance experience across markets including USA, Latin America, and Philippines.
Ghanashyam Hegde re-designated as Non-Executive Director after resigning as Company Secretary and Compliance Officer.
👀 What to Watch
This appears to be a routine internal leadership rotation within the P&G group. Investors should expect continuity in financial strategy and corporate governance.
PGHH Appoints Srividya Srinivasan as CFO and Executive Director in Management Reshuffle
Procter & Gamble Hygiene and Health Care Limited (PGHH) has announced a leadership transition effective July 1, 2026. Ms. Srividya Srinivasan, a P&G veteran with 20 years of global experience, will succeed Mr. Gaurav Bhartia as CFO and Executive Director for a five-year term. Additionally, Mr. Ghanashyam Hegde will transition from Executive Director to a Non-Executive Director role as he moves to a regional position within the P&G group.
Key Highlights
Ms. Srividya Srinivasan appointed as Executive Director and CFO for a 5-year term starting July 1, 2026.
Outgoing CFO Gaurav Bhartia to resign effective June 30, 2026, to take up a new assignment within P&G.
Ghanashyam Hegde re-designated as Non-Executive Director effective July 1, 2026, following his move to a regional P&G role.
Ms. Srinivasan brings 20 years of finance experience across markets including the USA, Latin America, and Philippines.
The changes are part of internal P&G talent rotations and are subject to shareholder approval at the 62nd AGM.
👀 What to Watch
Investors should view this as a routine internal leadership rotation typical of multinational corporations; no immediate impact on financial performance is expected.
PGHH Recommends Final Dividend of ₹60 per Share; FY26 PAT at ₹856.5 Crore
Procter & Gamble Hygiene and Health Care Limited (PGHH) has recommended a final dividend of ₹60 per equity share for the financial year ended March 31, 2026. The company reported a Profit After Tax (PAT) of ₹856.5 crore for the full year, with an EPS of ₹263.86. Annual revenue from operations stood at ₹4,290.4 crore. Investors should note that the previous financial year was a nine-month period, making direct year-on-year comparisons complex, though the company maintains a strong cash position of ₹557 crore.
Key Highlights
Recommended a final dividend of ₹60 per equity share (600% of face value) for FY 2025-26.
Reported annual revenue from operations of ₹4,29,042 Lakhs (₹4,290.4 Crore).
Net Profit for the year reached ₹85,650 Lakhs (₹856.5 Crore) with a Basic EPS of ₹263.86.
The dividend is scheduled for payment on or before September 18, 2026, subject to shareholder approval.
Cash and cash equivalents increased to ₹55,702 Lakhs from ₹46,637 Lakhs in the previous period.
👀 What to Watch
Investors should consider holding the stock for its consistent dividend payout and strong balance sheet. Monitor the upcoming Annual General Meeting for the final approval and the announcement of the record date for dividend eligibility.
PGHH FY26 PAT at ₹856.5 Cr; Recommends ₹60 Dividend per Share
Procter & Gamble Hygiene and Health Care Limited (PGHH) reported a Profit After Tax (PAT) of ₹85,650 Lakhs for the full year ended March 31, 2026, on a revenue of ₹4,29,042 Lakhs. For the fourth quarter, revenue stood at ₹94,132 Lakhs, a slight decrease from ₹99,163 Lakhs in the corresponding quarter of the previous year. The Board has recommended a final dividend of ₹60 per share, maintaining its high-payout ratio. Investors should note that the previous financial year was a 9-month transition period, making direct year-on-year annual comparisons complex.
Key Highlights
Reported full-year FY26 Revenue from Operations of ₹4,29,042 Lakhs and PAT of ₹85,650 Lakhs.
Recommended a final dividend of ₹60 per equity share (600% on face value of ₹10).
Q4 FY26 PAT stood at ₹15,313 Lakhs, a marginal 1.9% decrease compared to ₹15,610 Lakhs in Q4 FY25.
Full-year Earnings Per Share (EPS) reached ₹263.86.
Cash and cash equivalents strengthened to ₹55,702 Lakhs as of March 31, 2026.
👀 What to Watch
Investors should hold for the steady dividend yield and monitor the company's ability to revive volume growth in the feminine hygiene segment. The stock remains a defensive play with strong cash flow generation.
PGHH Appoints Srividya Srinivasan as CFO; Gaurav Bhartia to Step Down
Procter & Gamble Hygiene and Health Care Limited (PGHH) has announced a leadership transition effective July 1, 2026. Ms. Srividya Srinivasan, a P&G veteran with 20 years of experience, will take over as the Chief Financial Officer and Executive Director for a five-year term. She succeeds Mr. Gaurav Bhartia, who is moving to a new assignment within the P&G group. Additionally, Mr. Ghanashyam Hegde will transition from his role as Company Secretary to a Non-Executive Director position.
Key Highlights
Ms. Srividya Srinivasan appointed as CFO and Executive Director for a 5-year term starting July 1, 2026.
Outgoing CFO Gaurav Bhartia to resign effective June 30, 2026, to take up a new global assignment within P&G.
New CFO brings 20 years of experience across global markets including the USA, Latin America, and Philippines.
Ghanashyam Hegde re-designated as Non-Executive Director effective July 1, 2026, following his resignation as Company Secretary.
👀 What to Watch
Investors should view this as a routine internal leadership rotation typical of multinational corporations; no immediate impact on business operations is expected.
PGHH Sets August 17, 2026, as Record Date for Dividend and 62nd AGM
Procter & Gamble Hygiene and Health Care Limited (PGHH) has announced August 17, 2026, as the record date for its upcoming dividend and 62nd Annual General Meeting (AGM). The AGM is scheduled to take place on August 24, 2026. Shareholders appearing in the register on the record date will be eligible for the dividend payout, provided it is approved by members during the meeting. This follows the company's standard corporate governance cycle for its June-ending fiscal year.
Key Highlights
Record date for dividend eligibility and 62nd AGM participation is August 17, 2026.
The 62nd Annual General Meeting is scheduled to be held on August 24, 2026.
Dividend payment is contingent upon shareholder approval at the ensuing AGM.
The official notification was issued to BSE and NSE on May 28, 2026.
👀 What to Watch
Investors interested in the dividend should ensure they own the shares before the ex-dividend date (typically one business day prior to the record date). Monitor for the specific dividend amount if not already noted from the preceding earnings announcement.
PGHH Declares ₹195 Interim Dividend Including ₹25 Special Dividend for FY 2025-26
Procter & Gamble Hygiene and Health Care Limited (PGHH) has declared a substantial interim dividend of ₹195 per equity share for the financial year 2025-26. This total payout includes a one-time special dividend of ₹25 per share on a face value of ₹10. The company has set February 5, 2026, as the record date to determine shareholder eligibility for the payout. Detailed tax deduction at source (TDS) guidelines have been issued, requiring shareholders to submit necessary documentation by February 2, 2026.
Key Highlights
Interim dividend of ₹195 per equity share declared, including a ₹25 special dividend.
Record date for dividend entitlement is fixed as February 5, 2026.
Standard TDS of 10% for resident shareholders with PAN and 20% for those without.
Non-resident shareholders can avail DTAA benefits by submitting Form 10F and TRC.
Deadline for submission of tax-related documents is February 2, 2026, at 5 PM.
👀 What to Watch
Investors should ensure their PAN and bank account details are updated with their Depository Participant or RTA before the record date. Eligible shareholders should submit Form 15G/15H or other tax-exempt documents by February 2 to avoid higher TDS.
PGHH Q3 PAT Rises 12% to ₹301 Cr; Declares ₹195 Interim Dividend
Procter & Gamble Hygiene and Health Care (PGHH) reported a modest 1% YoY increase in sales to ₹1262 crore for the quarter ended December 31, 2025. Despite the slow top-line growth, Profit After Tax (PAT) surged by 12% to ₹301 crore, driven by operational efficiencies and a favorable product price-mix. A significant highlight for shareholders is the declaration of an interim dividend of ₹195 per share, which includes a ₹25 special dividend. The company continues to focus on its core brands like Whisper and Vicks through an integrated growth strategy.
Key Highlights
Sales for the quarter ended December 31, 2025, stood at ₹1262 crore, up 1% YoY.
Profit After Tax (PAT) increased by 12% YoY to reach ₹301 crore.
Declared a total interim dividend of ₹195 per equity share for FY 2025-26.
Dividend includes a one-time special dividend of ₹25 per equity share.
Profitability growth attributed to operational efficiencies and favorable product price-mix.
👀 What to Watch
Investors should find the high dividend payout and margin expansion attractive, though the 1% sales growth suggests a need to monitor volume recovery. The stock remains a strong defensive pick for income-seeking investors due to its robust cash flow and brand leadership.
PGHH Declares Rs 195 Interim Dividend; Q3 PAT Rises 4.5% to Rs 301.46 Crore
Procter & Gamble Hygiene and Health Care Limited (PGHH) has declared a significant interim dividend of Rs. 195 per share, which includes a one-time special dividend of Rs. 25. The company reported a steady performance for the quarter ended December 31, 2025, with net profit growing 4.5% year-on-year to Rs. 301.46 crore. Revenue from operations remained stable at Rs. 1,261.90 crore, while Earnings Per Share (EPS) improved to Rs. 92.87. The dividend payout represents a total cash outflow of Rs. 632.98 crore for the company.
Key Highlights
Declared interim dividend of Rs. 195 per equity share, including a Rs. 25 special dividend
Net Profit for the quarter ended Dec 2025 rose to Rs. 301.46 crore from Rs. 288.59 crore YoY
Revenue from operations stood at Rs. 1,261.90 crore compared to Rs. 1,247.03 crore in the previous year
Record date for dividend eligibility is fixed as February 5, 2026
Total dividend payout aggregates to Rs. 632.98 crore
👀 What to Watch
Investors should ensure they hold shares by the record date of February 5, 2026, to qualify for the high dividend payout. The company's consistent profitability and strong cash distribution reinforce its status as a high-quality defensive play in the FMCG sector.
